Back to library
Tissue Repair

BPC-157 (5 mg Vial)

Synthetic 15-amino-acid peptide derived from a gastric protein sequence. Studied for tissue-healing, cytoprotective, and anti-inflammatory properties in preclinical models.

Vial

5 mg vial

Category

Tissue Repair

Research highlights

Preclinical models report accelerated wound repair and anti-inflammatory activity.
Studied for angiogenic and collagen-deposition effects in damaged tissue.
Phase I oral safety trials have been completed; human efficacy data remain limited.

How this works

BPC-157 corresponds to a partial sequence of human gastric juice protein. Preclinical studies suggest it modulates nitric oxide pathways and growth-factor expression to promote angiogenesis and collagen deposition in damaged tissues. Animal models report accelerated healing of gut, tendon, ligament, and muscle injuries.

Storage

  • Lyophilized: freeze at −20 °C (−4 °F) in dry, dark conditions.
  • Reconstituted: refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.
  • Allow vials to reach room temperature before opening to reduce condensation.

Research-use notice

⚠️ All peptides on this site are not FDA approved and are not approved for human use outside of a clinical trial. f4Labs presents this material as a research reference only — not medical advice, diagnosis, or treatment guidance.

Peer-Reviewed References

Mechanism descriptions and research context are informed by the following published literature. Click any citation to view the source.

  1. 1
    Sikiric P, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL14736, Pliva, Croatia) and wound healing. Curr Pharm Des. 2011. doi:10.2174/138161211798357477.View source
  2. 2
    Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med. 2017. doi:10.1007/s00109-017-1570-9.View source
  3. 3
    Sikiric P, et al. Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Curr Neuropharmacol. 2016. doi:10.2174/1570159X13666151027112209.View source